Comparison of 80 W versus 120 W 532 nm Laser Prostatectomy for BPH
- 1 James Buchanan Brady Foundation Dept. of Urology, Weill Cornell Medical College, New York, USA
- 2 James Buchanan Brady Foundation Dept. of Urology, Weill Cornell Medical College, New York, USA
- 3 James Buchanan Brady Foundation Dept. of Urology, Weill Cornell Medical College, New York, USA
- 4 James Buchanan Brady Foundation Dept. of Urology, Weill Cornell Medical College, New York, USA
- 5 James Buchanan Brady Foundation Dept. of Urology, Weill Cornell Medical College, New York, USA
- 6 Department of Surgery, Weill Cornell Medical College, New York, USA
- 7 James Buchanan Brady Foundation Dept. of Urology, Weill Cornell Medical College, New York, USA
- 8 James Buchanan Brady Foundation Dept. of Urology, Weill Cornell Medical College, New York, USA
Abstract
Purpose : Improvements to photoselective vaporization of the prostate (PVP) have been made over time, particularly with the introduction of higher power systems. Few studies however have compared the performance of these systems to their predecessors. The purpose of this study was to compare the clinical and perioperative outcomes of 80 W vs. 120 W PVP. Materials and Methods : A series of 267 and 209 consecutive patients underwent 80 W and 120 W PVP, respectively, from September 2001 to May 2009 at Weill Cornell Medical College (GreenLight TM laser system, American Medical Systems, Inc., Minnetonka, MN). Data were collected on patient demographics, International Prostate Symptom Score (IPSS), prostate-specific antigen (PSA), and perioperative parameters. Maximum flow rate (Qmax), postvoid residual (PVR), and transrectal ultrasound prostate volume were recorded. Statistical analyses were carried out utilizing the Shapiro-Wilk, Mann-Whitney, Wilcoxon and unpaired t tests (SPSS 15.0, SPSS Inc., Chicago, IL, USA). Results : Baseline parameters were similar between the two groups except for greater median age (72.8 vs. 69.2 years, p = 0.01) and lower median PSA (2.0 vs. 3.3, p = 0.01) in the 80 W group. Median laser time was longer in the 80W group (85 vs. 51 minutes, p < 0.001) with a higher median energy utilized (253 vs. 210 kJ, p = 0.001). Final IPSS, Qmax, PVR, and PSA were equivalent between the two groups. Conclusions : In our series, PVP was safe and effective. Durable and similar improvements in symptoms and objective parameters were achieved in patients with both 80 W and 120 W laser systems. PVP with the 120 W system, however, provided faster and more efficient vaporization compared to the 80 W system .
- C. A. Thorpe and D. Neal, “Benign Prostatic Hyperplasia,” The Lancet, Vol. 361, No. 9366, 2003, pp. 1359-1367. doi:10.1016/S0140-6736(03)13073-5
- C. G. Roehrborn, J. D. McConnell, B. Saltzman, D. Bergner, T. Gray, P. Narayan, T. J. Cook, et al., “Storage (Irritative) and Voiding (Obstructive) Symptoms as Predictors of Benign Prostatic Hyperplasia Progression and Related Outcomes,” European Urology, Vol. 42, No. 1, 2002, pp. 1-6. doi:10.1016/S0302-2838(02)00210-5
- J. Fitzpatrick, “Which Bph Treatment Is the Most Clinically Efficacious and Cost-Effective?” Nature Clinical Practice Urology, Vol. 4, No. 7, 2007, pp. 358-359. doi:10.1038/ncpuro0806
- W. K. Mebust, “Transurethral Prostatectomy,” Urologic Clinics of North America, Vol. 17, No. 3, 1990, pp. 575-585.
- W. K. Mebust, H. L. Holtgrewe, A. T. Cockett and P. C. Peters, “Transurethral Prostatectomy: Immediate and Post-Operative Complications. A Cooperative Study of 13 Participating Institutions Evaluating 3885 Patients. 1989,” Journal of Urology, Vol. 167, No. 2, Pt. 2, 2002, pp. 999-1003.
- J. Rassweiler, D. Teber, R. Kunt and R. Hofmann, “Complications of Transurethral Resection of the Prostate (Turp)—Incidence, Management, and Prevention,” European Urology, Vol. 50, No. 5, 2006, pp. 969-979.
- A. Carter, H. Sells, M. Speakman, P. Ewings, P. O’Boyle and R. MacDonagh, “Quality of Life Changes Following Ktp/Nd: Yag Laser Treatment of the Prostate and Turp,” European Urology, Vol. 36, No. 2, 1999, pp. 92-98. doi:10.1159/000067977
- M. A. Hai and R. S. Malek, “Photoselective Vaporization of the Prostate: Initial Experience with a New 80 W Ktp Laser for the Treatment of Benign Prostatic Hyperplasia,” Journal of Endourology, Vol. 17, No. 2, 2003, pp. 93-96. doi:10.1089/08927790360587414
- R. S. Malek, D. M. Barrett and R. S. Kuntzman, “High-Power Potassium-Titanyl-Phosphate (Ktp/532) Laser Vaporization Prostatectomy: 24 Hours Later,” Urology, Vol. 51, No. 2, 1998, pp. 254-256. doi:10.1016/S0090-4295(97)00613-4
- O. Reich, M. S. Michel, P. Schneede, B. Liedl and A. Hofstetter, “Durability of Probes for Interstitial Laser Coagulation: Impact of Power Setting and Probe Design,” Journal of Endourology, Vol. 18, No. 3, 2004, pp. 299-302. doi:10.1089/089277904773582930
- R. Ruszat, M. Seitz, S. F. Wyler, C. Abe, M. Rieken, O. Reich, T. C. Gasser and A. Bachmann, “Greenlight Laser Vaporization of the Prostate: Single-Center Experience and Long-Term Results after 500 Procedures,” European Urology, Vol. 54, No. 4, 2008, pp. 893-901. doi:10.1016/j.eururo.2008.04.053